Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Mulligan

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Purification and characterization of retrovirally transduced hematopoietic stem cellsL M Spain, R C Mulligan
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1984
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host rangeR D Cone, R C Mulligan
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Two dominant-acting selectable markers for gene transfer studies in mammalian cellsS C Hartman, R C Mulligan
Biotechnology (Reading, Mass.)|January 1, 1992
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. 1984R D Cone, R C Mulligan
Cell|May 1, 1983
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirusR Mann, R C Mulligan, D Baltimore
Cell|November 7, 1986
Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cellsE Barklis, R C Mulligan, R Jaenisch
Journal of Internal Medicine|October 1, 1994
Transgenic animals as tools for the study of fibrinolysis in vivoP Carmeliet, R C Mulligan, D Collen
Journal of Virology|November 1, 1989
Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vectorH Stuhlmann, R Jaenisch, R C Mulligan
The Journal of Experimental Medicine|May 17, 2000
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccinesC Klein, H Bueler, R C Mulligan
Molecular and Cellular Biology|January 1, 1989
Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistanceH Stuhlmann, R Jaenisch, R C Mulligan
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Purification and characterization of retrovirally transduced hematopoietic stem cellsL M Spain, R C Mulligan
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1984
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host rangeR D Cone, R C Mulligan
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988
Two dominant-acting selectable markers for gene transfer studies in mammalian cellsS C Hartman, R C Mulligan
Biotechnology (Reading, Mass.)|January 1, 1992
High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range. 1984R D Cone, R C Mulligan
Cell|May 1, 1983
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirusR Mann, R C Mulligan, D Baltimore
Cell|November 7, 1986
Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cellsE Barklis, R C Mulligan, R Jaenisch
Journal of Internal Medicine|October 1, 1994
Transgenic animals as tools for the study of fibrinolysis in vivoP Carmeliet, R C Mulligan, D Collen
Journal of Virology|November 1, 1989
Transfer of a mutant dihydrofolate reductase gene into pre- and postimplantation mouse embryos by a replication-competent retrovirus vectorH Stuhlmann, R Jaenisch, R C Mulligan
The Journal of Experimental Medicine|May 17, 2000
Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccinesC Klein, H Bueler, R C Mulligan
Molecular and Cellular Biology|January 1, 1989
Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistanceH Stuhlmann, R Jaenisch, R C Mulligan
Pageof 13